期刊: JCO ONCOLOGY PRACTICE, 2021; 17 (3)
PURPOSE Intravenous (IV) bisphosphonates reduce the risk of skeletal-related events in patients with multiple myeloma (MM). However, data describing r......
期刊: JCO ONCOLOGY PRACTICE, 2020; 16 (8)
PURPOSE The growth in understanding of molecular biology and genomics has augmented the development of targeted cancer treatments; however, challenges......